Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
A Comparative Economical Evaluation of a Metered Dose Inhaler and Breath Actuated Inhaler Releasing Salbutamol or Beclomathazone Dipropionate for Asthma Treatment
Pneumon 2000;13(2):123-136
KEYWORDS
ABSTRACT
Our comparative economical study on cost differences between two discrete salbutamol (S) and beclomethazone dipropionate (BDP) release inhalers (metered dose inhalers, MDI vs breath actuated inhalers, BAI) resulted in the following conclusions. MDI seems to be 14% more expensive when it is used to release S by asthmatic patients, without any social insurance coverage, in comparison with the breath actuated device (BAI). When the devices under study where used to release BDP we also found cost difference. Pneumon 2000, 13 (2): 123-136
Share
RELATED ARTICLE
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
